Group One Trading’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,200
| Closed | -$294K | – | 8028 |
|
|
2025
Q3 | $294K | Sell |
6,200
-12,900
| -68% | -$625K | ﹤0.01% | 4246 |
|
|
2025
Q2 | $1.02M | Sell |
19,100
-20,600
| -52% | -$936K | ﹤0.01% | 2743 |
|
|
2025
Q1 | $1.61M | Buy |
39,700
+39,400
| +13,133% | +$1.67M | ﹤0.01% | 2030 |
|
|
2024
Q4 | $8.35K | Sell |
300
-8,300
| -97% | -$251K | ﹤0.01% | 6190 |
|
|
2024
Q3 | $247K | Buy |
8,600
+6,100
| +244% | +$159K | ﹤0.01% | 3431 |
|
|
2024
Q2 | $58.6K | Sell |
2,500
-19,200
| -88% | -$411K | ﹤0.01% | 4405 |
|
|
2024
Q1 | $548K | Sell |
21,700
-140,600
| -87% | -$3.38M | ﹤0.01% | 2641 |
|
|
2023
Q4 | $3.79M | Buy |
162,300
+5,800
| +4% | +$114K | 0.01% | 1344 |
|
|
2023
Q3 | $7.92M | Sell |
156,500
-6,000
| -4% | -$279K | 0.03% | 645 |
|
|
2023
Q2 | $7.59M | Buy |
162,500
+160,800
| +9,459% | +$7.37M | 0.02% | 682 |
|
|
2023
Q1 | $65K | Sell |
1,700
-229,300
| -99% | -$10.2M | ﹤0.01% | 4654 |
|
|
2022
Q4 | $12.7M | Buy |
231,000
+114,400
| +98% | +$4.9M | 0.03% | 605 |
|
|
2022
Q3 | $3.97M | Buy |
116,600
+114,100
| +4,564% | +$1.75M | 0.01% | 1346 |
|
|
2022
Q2 | $24K | Sell |
2,500
-6,900
| -73% | -$71.9K | ﹤0.01% | 6133 |
|
|
2022
Q1 | $133K | Buy |
+9,400
| New | +$165K | ﹤0.01% | 5216 |
|
|
2021
Q3 | – | Sell |
-9,100
| Closed | -$226K | – | 8107 |
|
|
2021
Q2 | $226K | Sell |
9,100
-112,600
| -93% | -$3.16M | ﹤0.01% | 5110 |
|
|
2021
Q1 | $3.53M | Buy |
+121,700
| New | +$3.68M | 0.01% | 1867 |
|
|
2020
Q3 | – | Sell |
-15,800
| Closed | -$394K | – | 6028 |
|
|
2020
Q2 | $394K | Buy |
15,800
+1,800
| +13% | +$41.1K | ﹤0.01% | 2827 |
|
|
2020
Q1 | $297K | Buy |
+14,000
| New | +$300K | ﹤0.01% | 2433 |
|
Other funds holding AKRO
Group One Trading's AKRO Position: Q4 2025 in Review
Group One Trading sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 20,381 shares — an estimated $968K sold.
Group One Trading first reported a position in AKRO in Q1 2020 and held it in 17 quarters. The position peaked at $6.83M in Q4 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Group One Trading reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 20,381 Akero Therapeutics shares in Q4 2025, an estimated $968K.
- Group One Trading first reported a position in Akero Therapeutics in Q1 2020 and held it in 17 quarters.
- Group One Trading's Akero Therapeutics position peaked at $6.83M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.